FAM86DP: A Protein Involved in Cell Signaling and Cancer Development

Target Name: FAM86DP

NCBI ID: G692099

FAM86DP

Other Name(s): FAM86D | family with sequence similarity 86 member D, pseudogene | Family with sequence similarity 86 member D, pseudogene

FAM86DP: A Protein Involved in Cell Signaling and Cancer Development

FAM86DP (FAM86D) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the FAM (FAM1-ASF/AFB1) family of proteins, which are known for their role in cell signaling and inflammation.

One of the unique features of FAM86DP is its ability to interact with the protein PDGF-BB (Platelet-derived growth factor-basic), which is a key regulator of cell growth and differentiation. This interaction between FAM86DP and PDGF-BB has been shown to play a role in the development and progression of various diseases, including cancer.

In addition to its interaction with PDGF-BB, FAM86DP has also been shown to interact with several other proteins, including the transcription factor NF-kappa-B (nuclear factor kappa B). This interaction between FAM86DP and NF-kappa-B has been shown to play a role in the regulation of inflammation and immune responses.

FAM86DP has also been shown to be involved in the regulation of cell death, as it has been shown to interact with the protein Bcl-2 (B cell lymphoma 2). This interaction between FAM86DP and Bcl-2 has been shown to play a role in the regulation of cell survival and the risk of cancer.

In conclusion, FAM86DP is a protein that has been shown to interact with several key regulators of cell signaling and development, including PDGF-BB, NF-kappa-B, and Bcl-2. These interactions have been shown to play a role in the regulation of various diseases, including cancer and immune responses. As a potential drug target, FAM86DP may be a valuable target for the development of new therapies for these and other diseases.

Protein Name: Family With Sequence Similarity 86 Member D, Pseudogene

The "FAM86DP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM86DP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets